Turning the Tide on Heart Disease - Permanently
Discover the next generation of cholesterol-lowering therapies.
Turning the Tide on Heart Disease - Permanently
Discover the next generation of cholesterol-lowering therapies.
About Ameliogenix Inc.
Our History
Ameliogenix Inc. was founded in 2023 with the goal of developing novel immunotherapies and gene-therapies to treat complex disorders that have relied on classical chemical drugs for too long. Side effects, off-target interactions, and inadequate efficacy of chemical drugs limit their accessibility to many suffering from complex health issues.
Our vision is to develop biologic agents that will offer fewer off-target interactions, better performance, and fewer side effects than what is currently offered. Our current efforts are focused on tackling the cardiovascular disease epidemic by addressing the demand for better-performing cholesterol-lowering therapies.
Our Values
At Ameliogenix Inc., we are committed to ethical and responsible biopharmaceutical research and development. We believe in putting patients first, and we are dedicated to developing products and therapies that are safe, effective, and accessible to all.